vs

Side-by-side financial comparison of Carlyle Group Inc. (CG) and DILLARD'S, INC. (DDS). Click either name above to swap in a different company.

Carlyle Group Inc. is the larger business by last-quarter revenue ($1.9B vs $1.5B, roughly 1.3× DILLARD'S, INC.). Carlyle Group Inc. runs the higher net margin — 18.8% vs 8.8%, a 10.0% gap on every dollar of revenue. On growth, Carlyle Group Inc. posted the faster year-over-year revenue change (84.1% vs 2.9%). DILLARD'S, INC. produced more free cash flow last quarter ($156.2M vs $-1.2B). Over the past eight quarters, Carlyle Group Inc.'s revenue compounded faster (66.2% CAGR vs -16.9%).

The Carlyle Group Inc. is an American multinational company with operations in private equity, alternative asset management and financial services. As of 2023, the company had $426 billion of assets under management.

Dillard's, Inc. is an American department store chain founded in 1938 by William T. Dillard. It is headquartered in Little Rock, Arkansas, and operates approximately 272 stores in 30 states. Currently, the largest number of stores are located in Texas with 57 and Florida with 42.

CG vs DDS — Head-to-Head

Bigger by revenue
CG
CG
1.3× larger
CG
$1.9B
$1.5B
DDS
Growing faster (revenue YoY)
CG
CG
+81.2% gap
CG
84.1%
2.9%
DDS
Higher net margin
CG
CG
10.0% more per $
CG
18.8%
8.8%
DDS
More free cash flow
DDS
DDS
$1.4B more FCF
DDS
$156.2M
$-1.2B
CG
Faster 2-yr revenue CAGR
CG
CG
Annualised
CG
66.2%
-16.9%
DDS

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
CG
CG
DDS
DDS
Revenue
$1.9B
$1.5B
Net Profit
$358.1M
$129.8M
Gross Margin
43.4%
Operating Margin
24.3%
11.5%
Net Margin
18.8%
8.8%
Revenue YoY
84.1%
2.9%
Net Profit YoY
69.8%
4.2%
EPS (diluted)
$0.96
$8.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CG
CG
DDS
DDS
Q4 25
$1.9B
$1.5B
Q3 25
$332.7M
$1.5B
Q2 25
$1.6B
$1.5B
Q1 25
$973.1M
$2.0B
Q4 24
$1.0B
$1.4B
Q3 24
$2.6B
$1.5B
Q2 24
$1.1B
$1.5B
Q1 24
$688.4M
$2.1B
Net Profit
CG
CG
DDS
DDS
Q4 25
$358.1M
$129.8M
Q3 25
$900.0K
$72.8M
Q2 25
$319.7M
$163.8M
Q1 25
$130.0M
$214.4M
Q4 24
$210.9M
$124.6M
Q3 24
$595.7M
$74.5M
Q2 24
$148.2M
$180.0M
Q1 24
$65.6M
$250.5M
Gross Margin
CG
CG
DDS
DDS
Q4 25
43.4%
Q3 25
36.6%
Q2 25
43.9%
Q1 25
34.9%
Q4 24
42.6%
Q3 24
37.6%
Q2 24
44.6%
Q1 24
36.6%
Operating Margin
CG
CG
DDS
DDS
Q4 25
24.3%
11.5%
Q3 25
25.8%
6.2%
Q2 25
28.0%
14.0%
Q1 25
17.6%
11.7%
Q4 24
25.7%
11.4%
Q3 24
29.9%
6.5%
Q2 24
20.5%
15.2%
Q1 24
17.5%
13.3%
Net Margin
CG
CG
DDS
DDS
Q4 25
18.8%
8.8%
Q3 25
0.3%
4.8%
Q2 25
20.3%
10.7%
Q1 25
13.4%
10.6%
Q4 24
20.4%
8.7%
Q3 24
22.6%
5.0%
Q2 24
13.9%
11.6%
Q1 24
9.5%
11.8%
EPS (diluted)
CG
CG
DDS
DDS
Q4 25
$0.96
$8.31
Q3 25
$0.00
$4.66
Q2 25
$0.87
$10.39
Q1 25
$0.35
$13.41
Q4 24
$0.56
$7.73
Q3 24
$1.63
$4.59
Q2 24
$0.40
$11.09
Q1 24
$0.18
$15.41

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CG
CG
DDS
DDS
Cash + ST InvestmentsLiquidity on hand
$2.0B
$1.1B
Total DebtLower is stronger
Stockholders' EquityBook value
$7.1B
$2.0B
Total Assets
$29.1B
$4.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CG
CG
DDS
DDS
Q4 25
$2.0B
$1.1B
Q3 25
$2.2B
$1.0B
Q2 25
$1.3B
$900.5M
Q1 25
$1.2B
$717.9M
Q4 24
$1.3B
$980.4M
Q3 24
$1.4B
$946.7M
Q2 24
$914.8M
$817.8M
Q1 24
$1.3B
$808.3M
Stockholders' Equity
CG
CG
DDS
DDS
Q4 25
$7.1B
$2.0B
Q3 25
$6.8B
$1.9B
Q2 25
$6.7B
$1.9B
Q1 25
$6.4B
$1.8B
Q4 24
$6.3B
$2.0B
Q3 24
$6.3B
$1.9B
Q2 24
$5.7B
$1.9B
Q1 24
$5.7B
$1.7B
Total Assets
CG
CG
DDS
DDS
Q4 25
$29.1B
$4.3B
Q3 25
$27.1B
$3.7B
Q2 25
$25.1B
$3.9B
Q1 25
$24.1B
$3.5B
Q4 24
$23.1B
$4.1B
Q3 24
$22.7B
$3.7B
Q2 24
$22.3B
$3.9B
Q1 24
$20.8B
$3.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CG
CG
DDS
DDS
Operating Cash FlowLast quarter
$-1.2B
$186.5M
Free Cash FlowOCF − Capex
$-1.2B
$156.2M
FCF MarginFCF / Revenue
-65.1%
10.6%
Capex IntensityCapex / Revenue
2.2%
2.1%
Cash ConversionOCF / Net Profit
-3.34×
1.44×
TTM Free Cash FlowTrailing 4 quarters
$-3.4B
$781.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CG
CG
DDS
DDS
Q4 25
$-1.2B
$186.5M
Q3 25
$-1.6B
$86.8M
Q2 25
$-168.8M
$232.6M
Q1 25
$-352.1M
$364.7M
Q4 24
$-352.8M
$173.5M
Q3 24
$791.9M
$-68.4M
Q2 24
$-1.3B
$244.4M
Q1 24
$71.1M
$436.5M
Free Cash Flow
CG
CG
DDS
DDS
Q4 25
$-1.2B
$156.2M
Q3 25
$-1.6B
$60.1M
Q2 25
$-186.3M
$215.8M
Q1 25
$-368.8M
$349.3M
Q4 24
$-379.5M
$145.4M
Q3 24
$772.8M
$-94.3M
Q2 24
$-1.3B
$209.2M
Q1 24
$56.9M
$408.2M
FCF Margin
CG
CG
DDS
DDS
Q4 25
-65.1%
10.6%
Q3 25
-475.7%
4.0%
Q2 25
-11.8%
14.1%
Q1 25
-37.9%
17.3%
Q4 24
-36.8%
10.2%
Q3 24
29.3%
-6.3%
Q2 24
-120.4%
13.5%
Q1 24
8.3%
19.2%
Capex Intensity
CG
CG
DDS
DDS
Q4 25
2.2%
2.1%
Q3 25
7.0%
1.8%
Q2 25
1.1%
1.1%
Q1 25
1.7%
0.8%
Q4 24
2.6%
2.0%
Q3 24
0.7%
1.7%
Q2 24
1.7%
2.3%
Q1 24
2.1%
1.3%
Cash Conversion
CG
CG
DDS
DDS
Q4 25
-3.34×
1.44×
Q3 25
-1732.78×
1.19×
Q2 25
-0.53×
1.42×
Q1 25
-2.71×
1.70×
Q4 24
-1.67×
1.39×
Q3 24
1.33×
-0.92×
Q2 24
-8.57×
1.36×
Q1 24
1.08×
1.74×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CG
CG

Fund Management Fee$606.8M32%
Other$528.7M28%
Global Private Equity Segment$307.3M16%
Global Credit Segment$238.0M13%
Carlyle Alp Invest Segment$124.6M7%
Incentive Fee$55.4M3%
Fee Related Performance Revenues$29.2M2%
Investment Advice$11.1M1%

DDS
DDS

Segment breakdown not available.

Related Comparisons